Novo Nordisk creates AI division to help novel drug development

A new center in Seattle, US, will discover and develop new drugs using artificial intelligence. Recruitment for the new unit has begun.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL PEDERSEN

The use of artificial intelligence (AI) is gaining popularity within the healthcare sector, where the technology is used to optimize hospital scheduling, indentify at-risk patients, support decision-making tools and more.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading